Global Spirometer Market By Product Type (Table-Top Spirometer, Hand-Held Spirometer, PC Based Spirometer), Technology (Volume Measurement Spirometer, Flow Measurement Spirometer, Peak Flow Meter), Mechanism (Flow-Sensing Spirometer, Peak Flow Meters), Disease (Asthma, Bronchitis, Emphysema, Chronic Obstructive Lung Disease, Lung Cancer, Others), Disposable Components (Filters, Sensors, Tubes), Application (Diagnostics, Therapeutics), End-User (Hospitals, Clinics, Homecare), Distribution Channel (Over the Counter, Direct Tender) – Industry Trends and Forecast to 2029
Market Analysis and Size
According to the World Health Organization (WHO), asthma affects approximately 300 million people worldwide, and 250,000 people have died as a result of asthma. In 2019, approximately 65 million people worldwide had COPD, with approximately 16 million Americans having COPD, and the number is expected to rise in the future. Spirometers are widely used in the treatment, diagnosis, monitoring, and management of respiratory disorders.
Data Bridge Market Research analyses that the spirometer market is expected to reach the value of USD 1467.89 million by the year 2029, at a CAGR of 10.9% during the forecast period. The increasing number of respiratory related patients will aid in the expansion of the spirometer market.
Market Definition
Spirometry is a common test used to assess how well an individual's lungs work by measuring how much air they inhale and exhale. It aids in the diagnosis of asthma, chronic obstructive pulmonary disease (COPD), and other breathing-related conditions. A spirometer is used for the test, which aids in monitoring lung condition and determining whether or not a treatment for a chronic lung condition is effective.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product Type (Table-Top Spirometer, Hand-Held Spirometer, PC Based Spirometer), Technology (Volume Measurement Spirometer, Flow Measurement Spirometer, Peak Flow Meter), Mechanism (Flow-Sensing Spirometer, Peak Flow Meters), Disease (Asthma, Bronchitis, Emphysema, Chronic Obstructive Lung Disease, Lung Cancer, Others), Disposable Components (Filters, Sensors, Tubes), Application (Diagnostics, Therapeutics), End-User (Hospitals, Clinics, Homecare), Distribution Channel (Over the Counter, Direct Tender)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Ireland), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Allergan (Ireland), AstraZeneca (U.K.), Johnson & Johnson Private Limited (U.S.), Cipla Inc. (U.S.), Abbott (U.S.), AbbVie Inc. (U.S.), Merck KGaA (Germany), LEO Pharma A/S (Denmark), Bausch Health Companies Inc. (Canada), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Hikma Pharmaceuticals PLC (U.K.), Fresenius Kabi AG (Germany), Amneal Pharmaceuticals LLC. (U.S.)
|
|
Opportunities
|
|
|
|
|
Spirometer Market Dynamics
Drivers
- The rise in the respiratory diagnosis devices
Increase in demand for devices to diagnose various respiratory diseases such as tuberculosis, asthma, chronic obstructive diseases, cystic fibrosis, black lung, and others. The increasing technological advancements in spirometers to achieve higher yield and improved patient comfort without complications, as well as the rise in the adoption of innovative packaging procedures to prevent any type of bacterial infection, drive the spirometer market growth.
The growing preference for home healthcare
The growing preference for home healthcare, which allows patients to receive treatment in the comfort of their own homes, as well as the development of tele-spirometers, all have an impact on the spirometer market.
Regulatory Compliance
Maintaining compliance with medical reforms and regulations raises the demand for these solutions.
- Government investments for healthcare interoperability
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the spirometer market.
.Restraints/Challenges
lengthy time required to perform tests is expected to obstruct the spirometer market growth. The risk of inaccuracy and need for skilled professionals are projected to challenge the spirometer market in the forecast period..
This spirometer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the spirometer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Spirometer Market
COVID-19 is an infectious disease caused by a newly discovered coronavirus. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. This pandemic has hampered growth in a wide range of economies. Respiratory diseases are among the world's leading causes of death, accounting for five of the top thirty. Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States. The COVID-19 outbreak has resulted in an increase in the occurrence of respiratory diseases. The pandemic has caused havoc in health-care systems around the world. There is expected to be an increase in the number of ARDS patients who require respiratory support, as well as an increase in the demand for spirometers.
.Recent Development
- Vitalograph will launch the next-generation Pneumotrac spirometer in the United States in April 2021, along with the upgraded Spirotrac 6 software.
- Vyaire Medical will launch the AioCare mobile spirometry system in more than 15 countries across Europe, the Middle East, and Australia in March 2021.
Global Spirometer Market Scope
The spirometer market is segmented on the basis product type, technology, mechanism, disease, disposable components, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product type
- Table-top spirometer
- Hand-held spirometer
- PC based spirometer
On the basis of product type, the spirometer market is segmented into table-top spirometer, hand-held spirometer and PC based spirometer.
Technology
- Volume measurement spirometer
- Flow measurement spirometer
- Peak flow meter
On the basis of technology, the spirometer market is segmented into volume measurement spirometer, flow measurement spirometer and peak flow meter.
Mechanism
- Flow-sensing spirometer
- Peak flow meters
On the basis of mechanism, the spirometer market is segmented into flow-sensing spirometer and peak flow meters.
Diseases
- Asthma
- Bronchitis
- Emphysema
- Chronic obstructive lung disease
- Lung cancer
- Others
On the basis of disease, the spirometer market is segmented into asthma, bronchitis, emphysema, chronic obstructive lung disease, lung cancer and others.
Disposable components
- Filters
- Sensors
- Tubes
On the basis of disposable components, the spirometer market is segmented into filters, sensors and tubes.
Application
- Diagnostics
- Therapeutics
On the basis of application, the spirometer market is segmented into diagnostics and therapeutics.
End user
- Hospitals
- Clinics
- Home care
On the basis of end-user, the spirometer market is segmented into hospitals, clinics and homecare.
Distribution channel
- Over the counter
- Direct tender
On the basis of distribution channel, the spirometer market is segmented into over the counter and direct tender.
Spirometer Market Regional Analysis/Insights
The spirometer market is analysed and market size insights and trends are provided by country, product type, technology, mechanism, disease, disposable components, application, end-user and distribution channel as referenced above.
The countries covered in the spirometer market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the spirometer market because of the high prevalence of chronic obstructive pulmonary disease (COPD). Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the improving primary care initiatives for early diagnosis and management of chronic lung diseases such as asthma and COPD.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The spirometer market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for spirometer market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the spirometer market. The data is available for historic period 2010-2020.
Competitive Landscape and Spirometer Market Share Analysis
The spirometer market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to spirometer market.
Some of the major players operating in the spirometer market are
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Ireland)
- Sanofi (France)
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (U.K.)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Eli Lilly and Company (U.S.)
- Merck & Co., Inc. (U.S.)
- Allergan (Ireland)
- AstraZeneca (U.K.)
- AbbVie Inc. (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Cipla Inc. (U.S.)
- Abbott (U.S.)
- Merck KGaA (Germany)
- LEO Pharma A/S (Denmark)
- Bausch Health Companies Inc. (Canada)
- Sun Pharmaceutical Industries Ltd. (India)
- Aurobindo Pharma (India)
- Lupin (India)
- Hikma Pharmaceuticals PLC (U.K.)
- Fresenius Kabi AG (Germany)
- Amneal Pharmaceuticals LLC. (U.S.)
SKU-